Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN57577615
ISRCTN57577615
Completed
Not Applicable

Botulinum toxin-A in sensory urgency

Guy's and St Thomas' NHS Trust (UK)0 sites64 target enrollmentSeptember 21, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSensory urgency, overactive bladderUrological and Genital Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sensory urgency, overactive bladder
Sponsor
Guy's and St Thomas' NHS Trust (UK)
Enrollment
64
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 21, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Guy's and St Thomas' NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Informed consent to participate
  • •2\. Male and females 18 to 80 years of age
  • •3\. Symptoms of overactive bladder
  • •4\. Refractory to anticholinergics
  • •5\. No evidence of detrusor overactivity on urodynamic studies

Exclusion Criteria

  • •1\. Pregnancy or planned pregnancy in the next year
  • •2\. Breast feeding
  • •3\. Painful bladder syndrome or interstitial cystitis
  • •4\. Evidence of significant outflow obstruction
  • •5\. Indwelling catheter
  • •6\. Previous bladder surgery e.g. augmentation cystoplasty
  • •7\. Previous urological use of botulinum toxin
  • •8\. Other bladder pathology e.g. tumours, active infection
  • •9\. Proven detrusor overactivity
  • •10\. Current anticoagulation treatment e.g. heparin, warfarin

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Botulinum toxin-A in Sensory Urgency - BTXSENSSensory Urinary Urgency. This is a condition where patients have urinary urgency (sudden desire to urinate which cannot be deferred) /- urge incontinence (urine leakage) and usually is accompanied by frequency (frequent passage of urineusually > 8/day)and nocturia (passing urine at night ie getting up from sleep). No abnormal bladder muscle overactivity, however, is present.MedDRA version: 9.1Level: LLTClassification code 10059617Term: Overactive bladder
EUCTR2006-000129-76-GBGuy's & St Thomas' NHS Foundation Trust64
Completed
Phase 4
A double blind randomised, placebo-controlled trial evaluating the effect of Botox injected into the pelvic floor of women with chronic pelvic pain and levator spasm.
ACTRN12605000559617Allergan Australia Pty Ltd60
Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Active, not recruiting
Not Applicable
Responsiveness to botulinum toxinum type A in complex regional pain syndrome related fixed dystonia
EUCTR2010-019997-33-NLeiden University Medical Center
Completed
Not Applicable
Responsiveness to botulinum toxinum type A in complex regional pain syndrome related fixed dystonia10028037post traumatic dystrophyreflex sympathetic dystrophy
NL-OMON34320eids Universitair Medisch Centrum56